NTLA

NTLA EBITDA Margin

-656.03%TTM

Period ending:

NTLA FY EBITDA Margin%
NTLA FY EBITDA Margin156.21%-1457.98%
2014-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

NTLA ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 12 observations from Dec 31, 2014 to Dec 31, 2025.

Intellia Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-586.3235%
-878.9951%
-1,301.7671%
-895.2514%
-789.6439%
-224.6301%
-233.8144%
-283.9127%
-254.857%
-188.452%
-216.4295%
0%

Compare ebitda margin

All NTLA financial metrics · NTLA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.